Summary
Abbott Laboratories (ABT) has announced a significant leadership transition within its finance department, effective September 1, 2023. This 8-K filing details the appointments of key finance executives, including Robert E. Funck, Jr. as Executive Vice President, Finance. Philip P. Boudreau will step into the role of Senior Vice President, Finance and Chief Financial Officer, continuing to report to Mr. Funck. John A. McCoy, Jr. has been appointed Vice President, Controller. These appointments reflect a strategic alignment of financial leadership within Abbott. Mr. Boudreau's long tenure and extensive experience within the company, including his recent role as Vice President, Controller, position him well for his new CFO responsibilities. Mr. McCoy's background, including his recent role as Vice President, Treasurer, also provides a solid foundation for his new position as Controller. Investors should monitor how these leadership changes impact financial strategy and execution moving forward.
Key Highlights
- 1Abbott Laboratories announced executive appointments in its finance department, effective September 1, 2023.
- 2Philip P. Boudreau has been appointed Senior Vice President, Finance and Chief Financial Officer (CFO).
- 3Robert E. Funck, Jr. has been appointed Executive Vice President, Finance.
- 4John A. McCoy, Jr. has been appointed Vice President, Controller.
- 5Mr. Boudreau, the new CFO, has a long history with Abbott, joining in 1997 and holding various divisional controller roles.
- 6Mr. McCoy, the new Controller, joined Abbott in 2017 and previously served as Vice President, Treasurer.
- 7Details on Mr. Boudreau's compensation include a base salary of $600,000 and a target annual bonus of 90% of base salary.